The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids
Open accessAbstract
G protein-coupled receptor 43 (GPR43) has been identified as a receptor for short-chain fatty acids that include acetate and propionate. A potential involvement of GPR43 in immune and inflammatory response has been previously suggested because its expression is highly enriched in immune cells. GPR43 is also expressed in a number of other tissues including adipocytes; however, the functional consequences of GPR43 activation in these other tissues are not clear. In this report, we focus on the potential functions of GPR43 in adipocytes. We show that adipocytes treated with GPR43 natural ligands, acetate and propionate, exhibit a reduction in lipolytic activity. This inhibition of lipolysis is the result of GPR43 activation, because this effect is abolished in adipocytes isolated from GPR43 knockout animals. In a mouse in vivo model, we show that the activation of GPR43 by acetate results in the reduction in plasma free fatty acid levels without inducing the flushing side effect that has been observed by the activation of nicotinic acid receptor, GPR109A. These results suggest a potential role for GPR43 in regulating plasma lipid profiles and perhaps aspects of metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Room, R., Babor, T., & Rehm, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17870-2 · Cited by 1,625 · cited 1×
“Excessive chronic alcohol consumption is causally associated with more than 60 different medical conditions (23).”
BackgroundPUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., & Offermanns, S. (2003) · Nature Medicine · doi:10.1038/nm824 · Cited by 791
Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43
Hong, Y.-H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.-C., Feng, D. D., Chen, C., Lee, H.-G., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0545 · Cited by 612
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
CARLSON, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 581
Nilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid
Wise, A., Foord, S. M., Fraser, N. J., Barnes, A. A., Elshourbagy, N., Eilert, M., Ignar, D. M., Murdock, P. R., Steplewski, K., Green, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210695200 · Cited by 539
ETHANOL METABOLISM AND PRODUCTION OF FREE ACETATE IN THE HUMAN LIVER
Lundquist, F., Tygstrup, N., Winkler, K., Mellemgaard, K., & Munck-Petersen, S. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104574 · Cited by 351
GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
Benyó, Z., Gille, A., Kero, J., Csiky, M., Suchánková, M. C., Nüsing, R. M., Moers, A., Pfeffer, K., & Offermanns, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23626 · Cited by 340
Molecular identification of nicotinic acid receptor
Soga, T., Kamohara, M., Takasaki, J., Matsumoto, S.-I., Saito, T., Ohishi, T., Hiyama, H., Matsuo, A., Matsushime, H., & Furuichi, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00342-5 · Cited by 316
Cheng, K., Wu, T.-J., Wu, K. K., Sturino, C., Metters, K., Gottesdiener, K., Wright, S. D., Wang, Z., O’Neill, G., Lai, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601574103 · Cited by 268
Siler, S. Q., Neese, R. A., & Hellerstein, M. K. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.5.928 · Cited by 231
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216 · cited 1×
“The lipase activity was measured using a LPL assay kit according to the manufacturer’s instruction (Roar Biomedicals, New York, NY; RB-LPL2) (12).”
MethodThe nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
OFFERMANNS, S. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.008 · Cited by 180
The G-protein-coupled receptor 40 family (GPR40–GPR43) and its role in nutrient sensing
Covington, D. K., Briscoe, C. A., Brown, A. J., & Jayawickreme, C. K. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340770 · Cited by 165
Latest Development in Drug Discovery on G Protein-coupled Receptors
Publisher, B. S. P. B. S. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306778559403 · Cited by 131
Fatty acid receptors as new therapeutic targets for diabetes
Rayasam, G. V., Tulasi, V. K., Davis, J. A., & Bansal, V. S. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.661 · Cited by 113
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid
Pike, N. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27160 · Cited by 71
Effect of acetate and propionate on fasting hepatic glucose production in humans.
Laurent, C., Simoneau, C., Marks, L. M., Braschi, S., Champ, M. M. J., Charbonnel, B. H., & Krempf, M. (1995) · PubMed · Cited by 68
Acute Cardiovascular and Metabolic Effects of Acetate in Men
Suokas, A., Kupari, M. M., Heikkilä, J., Lindros, K. O., & Ylikahri, R. (1988) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1988.tb00132.x · Cited by 41
Pike, N. B., & Wise, A. (2004) · PubMed · Cited by 40
An update on alcohol and atherosclerosis
Li, J. M., & Mukamal, K. J. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00008 · Cited by 39
Beta-adrenergic blockade and lipoprotein lipase activity in rat tissues after acute exercise
Paulin, A., Lalonde, J., & Deshaies, Y. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.261.4.r891 · Cited by 11
Orphan GPCR target validation.
Thomsen, W. J., Leonard, J. N., & Behan, D. P. (2004) · PubMed · Cited by 8
Konstantinov, V. O. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00013 · Cited by 2
Cited by
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Short-chain fatty acids in control of body weight and insulin sensitivity
Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4611 · Cited by 1,771
Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2852 · Cited by 1,512
Metadata
- Authors
- Ge, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.-L., Tian, H., & Li, Y.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2008-05-22
- Volume
- 149
- Issue
- 9
- Pages
- 4519-4526
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2144701449
- Cited by
- 475
- References
- 26
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.